FRAZIER LIFESCIENCES ACQUISITION CORPORATION Quotes Frazier Lifesciences Acquisition Corporation
Equities
NAMS
NL00150012L7
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.4 EUR | -10.36% |
|
-0.87% | +73.77% |
| 05-16 | Transcript : NewAmsterdam Pharma Company N.V. - Special Call | |
| 05-15 | TD Cowen Starts NewAmsterdam Pharma With Buy Rating | MT |
Quotes 5-day view
End-of-day quote Nasdaq| 2024-05-23 | 2024-05-24 | 2024-05-28 | 2024-05-29 | 2024-05-30 | |
|---|---|---|---|---|---|
| Last | 19.1 € | 18.82 € | 19.41 € | 18.98 € | 19.41 € |
| Volume | 35 045 | 131 706 | 236 777 | 103 242 | 236 777 |
| Change | -2.45% | -1.47% | +3.13% | -2.22% | -10.36% |
| Opening | 19.85 | 19.11 | 19.17 | 19.45 | 19.17 |
| High | 20.17 | 20.33 | 19.72 | 19.79 | 19.72 |
| Low | 19.04 | 18.51 | 18.46 | 18.87 | 18.46 |
Performance
| 1 day | -10.36% | ||
| 1 week | -0.87% | ||
| Current month | -11.00% | ||
| 1 month | -10.39% | ||
| 3 months | -15.02% | ||
| 6 months | +94.29% | ||
| Current year | +73.77% | ||
| 1 year | +43.04% | ||
| 3 years | +100.10% |
Volumes
marketsDaily volume
236 777
Avg. Volume 20 sessions
119 815
Avg. Volume 20 sessions
2 084 781.00
Avg. Volume 20 sessions USD
2 255 191.00
Record volume 1
2 900 962
Record volume 2
2 571 785
Record volume 3
1 904 169
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
1 578 873 093
Capitalization (USD)
1 707 930 180
Net sales (EUR)
13 005 070
Net sales (USD)
14 068 104
Number of employees
40
Sales / Employee (EUR)
325 127
Sales / Employee (USD)
351 703
Free-Float
94.29 %
Free-Float capitalization (EUR)
1 488 619 082
Free-Float capitalization (USD)
1 610 298 806
Average Daily Capital Traded
0.13%
Highs and lows
1 week
18.46
20.33
1 month
18.4623.01
Current year
11.1826.35
1 year
5.6326.35
3 years
5.6332.88
5 years
5.6332.88
10 years
5.6332.88
Indicators
Moving average 5 days
19.28
Moving average 20 days
20.71
Moving average 50 days
20.97
Moving average 100 days
20.60
Price spread / (MMA5)
+10.80%
Price spread / (MMA20)
+19.02%
Price spread / (MMA50)
+20.52%
Price spread / (MMA100)
+18.39%
STIM
RSI 9 days
38.67
RSI 14 days
40.55
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -10.36% | -0.87% | +73.77% | +43.04% | 1.71B | ||
| -1.32% | -1.47% | +8.38% | +33.63% | 114B | ||
| -0.61% | -1.68% | +10.13% | +33.41% | 104B | ||
| -0.96% | -8.90% | -11.69% | -11.47% | 22.5B | ||
| -1.05% | +3.55% | +1.14% | -5.70% | 22.57B | ||
| -0.31% | -5.48% | -11.18% | -30.30% | 17.95B | ||
| +0.02% | -4.19% | -41.90% | -36.71% | 16.48B | ||
| -1.04% | -9.77% | -16.00% | -36.04% | 15.82B | ||
| -4.07% | -3.35% | +2.28% | +47.73% | 13.55B | ||
| +2.57% | -9.40% | +20.54% | -8.34% | 10.99B | ||
| +0.96% | -1.22% | -30.06% | -33.34% | 7.67B | ||
| -1.18% | -4.86% | +8.11% | +38.64% | 7.39B | ||
| -0.49% | -2.04% | -3.77% | +22.16% | 7.44B | ||
| +4.14% | +1.11% | +5.28% | +47.74% | 7.6B | ||
| -2.43% | +1.21% | +242.67% | +199.25% | 7.04B | ||
| +11.27% | +121.56% | +72.73% | +184.89% | 7.96B | ||
| Average | -0.84% | +4.68% | +20.65% | +30.54% | ||
| Weighted average by Cap. | -0.77% | -0.04% | +8.16% | +24.08% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +69.92% | ||
| 2023 | +2.48% | ||
| 2022 | +11.79% | ||
| 2021 | -9.72% |
- Stock Market
- Equities
- NAMS Stock
- Quotes Frazier Lifesciences Acquisition Corporation
